Digest Network Come funziona
Network
/
Società
Te
Non verificato

Tenpoint Therapeutics, Ltd.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaOtticaSalute

17 comunicati stampa

Guarda tutti i comunicati
13/07/2026
Biotecnologia
Salute
Farmaceutica
Ottica
Medicina - Varie
Industria
Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
13/07/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Ottica
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
29/06/2026
Tenpoint Therapeutics Launches YUVEZZI™ Direct-to-Consumer Campaign Featuring a Cast of Hand-Crafted Puppets Giving a Voice to the Everyday Fusses of Blurry Close-Up Vision
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
07/04/2026
Mercato del lavoro
Biotecnologia
Sanità
Salute
Farmaceutica
Ottica
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
29/01/2026
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Ottica
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
29/01/2026
Multimedialità
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Ottica
Biotecnologia
Industria
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
16/12/2025
Eventi
Scienza
Biotecnologia
Farmaceutica
Ottica
Sanità
Salute
Medicina - Varie
Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
05/11/2025
Biotecnologia
Farmaceutica
Ottica
Salute
Industria
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
13/10/2025
Associazioni/Professionisti
Salute
Finanza
Sanità
Farmaceutica
Ottica
Biotecnologia
Eventi
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0
08/09/2025
Salute
Igiene alimentare
Scienza
Farmaceutica
Ottica
Biotecnologia
Finanza
Eventi
Fiere
Industria
Tenpoint Therapeutics, Ltd. to Participate in Upcoming Eye Care Conferences
Fonte
Tenpoint Therapeutics, Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0